Sumitomo Pharma Co., Ltd.

4506.T · JPX
Analyze with AI
3/31/2025
3/31/2024
3/31/2023
3/31/2022
Operating Activities
Net Income¥24-¥315-¥97¥41
Dep. & Amort.¥26¥38¥41¥38
Deferred Tax¥0¥0¥0¥0
Stock-Based Comp.¥0¥0¥0¥0
Change in WC-¥19-¥96¥35-¥34
Other Non-Cash-¥14¥131¥33-¥14
Operating Cash Flow¥17-¥242¥12¥31
Investing Activities
PP&E Inv.-¥8-¥16-¥13-¥13
Net Acquisitions¥1¥9¥30-¥4
Inv. Purchases-¥2-¥5-¥6-¥26
Inv. Sales/Matur.¥108¥34¥10¥19
Other Inv. Act.-¥0¥10¥31¥5
Investing Cash Flow¥100¥33¥52-¥18
Financing Activities
Debt Repay.-¥112¥84¥65-¥5
Stock Issued¥0¥0¥0¥0
Stock Repurch.¥0¥0¥0¥0
Dividends Paid-¥0-¥3-¥11-¥11
Other Fin. Act.¥4-¥3-¥201-¥5
Financing Cash Flow-¥109¥78-¥147-¥21
Forex Effect-¥0¥15¥24¥18
Net Chg. in Cash-¥6-¥114-¥60¥9
Supplemental Information
Beg. Cash¥29¥143¥203¥194
End Cash¥23¥29¥143¥203
Free Cash Flow¥3-¥258-¥1¥18
Sumitomo Pharma Co., Ltd. (4506.T) Financial Statements & Key Stats | AlphaPilot